In the CIS group, COX-2 expression was significantly associated with disease recurrence and progression, but not with BC related survival (as in our analysis, data not shown), while in the stage T1 the TCC COX-2 expression was not associated with clinical or pathological parameters or clinical outcome [27]. Here, PTGS2 is linked to tarsal-carpal coalition syndrome.